ArticleAmerican journal of respiratory and critical care medicine2024
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.
Open access · hybridAbstract readMulticenter Study
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
10.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.
- Global Epidemiology and Disease Burden of Human Parainfluenza Virus in Adults: A Systematic Review.Reviews in medical virology · 2026Pooled it
- Impact of RSV infection on mortality, rehospitalization, and long-term pulmonary, cardiovascular, and functional outcomes in hospitalized adults: a systematic review and meta-analysis.Virology journal · 2025Pooled it
- Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.Current allergy and asthma reports · 2025Pooled it
- Clinical Burden of Disease and Demographics in Older Adults Hospitalized with RSV Infection in England: A Retrospective Cohort Study.Infectious diseases and therapy · 2026Article
- Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands.Infectious diseases and therapy · 2026Article
- Adjuvanted RSVPreF3 vaccine impact over three respiratory syncytial virus seasons in older adults with comorbidities.ERJ open research · 2026Article
- Forecasting the Multidimensional Burdens of Hospital Admissions in LRTIs and COPD: Projections of Healthcare Expenditures, Resource Utilization, and Socioeconomic and Environmental Outcomes for Switzerland.Infectious diseases and therapy · 2026Article
- Clinical Impact of RSV Vaccination in Hemodialysis Patients: Real-World Evidence on Hospitalization Risk and the Role of Chronic Lung Disease.Advances in respiratory medicine · 2026Article
- Respiratory Syncytial Virus Immunization Strategies for Older Adults in Gulf Cooperation Council Countries: Expert Consensus and Recommendations.Infectious diseases and therapy · 2026Article
- Respiratory syncytial virus is associated with a higher disease burden than influenza and SARS-CoV-2 in adults with chronic lung disease: a multi-center cohort study.Respiratory research · 2026Article
- Risk of Cardiorespiratory Events Following Respiratory Syncytial Virus-Related Hospitalization.JAMA network open · 2026Article
- Expert Consensus Statement on the Disease Burden and Vaccination for Respiratory Syncytial Virus Infection in Adults.Tuberculosis and respiratory diseases · 2026Article
- Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort study.Human vaccines & immunotherapeutics · 2025Article
- Burden and Characteristics of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis from 2017 to 2023.Viruses · 2025Article
- Age-Dependent Risk of Bronchial Asthma Exacerbation in Respiratory Syncytial Virus Co-infection.Lung · 2025Article
- Impact of RSV Infection in Transplant and Immunocompromised Population: Incidence and Co-Infections: Retrospective Analysis of a Single Centre.Journal of clinical medicine · 2025Article
- Addressing the Underestimated Burden of RSV in Older Adults in Europe: Epidemiology, Surveillance Gaps, and Public Health Implications.Vaccines · 2025Review
- Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019.Influenza and other respiratory viruses · 2025Observational
- Vaccination in Chronic Obstructive Pulmonary Disease.Vaccines · 2025Review
- A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection.Infectious diseases and therapy · 2025Review
Corrections and comments
- Commented on by
Authors and funding
23 authors at 7 institutions in 5 countries.
Dexter J WisemanNational Heart and Lung Institute, Imperial College London, London, United Kingdom.ORCID 0000-0002-6398-7450
Ryan S ThwaitesNational Heart and Lung Institute, Imperial College London, London, United Kingdom.ORCID 0000-0003-3052-2793
Andrew I RitchieNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Lydia FinneyNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Mairi MacleodNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Faisal KamalNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Hassan ShahbakhtiNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Lisa H van SmoorenburgDepartment of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Hiub A M KerstjensDepartment of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Joanne WildenbeestDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands.
Deniz ÖnerInfectious Diseases Translational Biomarkers, Janssen Pharmaceutica, Beerse, Belgium.
Jeroen AerssensInfectious Diseases Translational Biomarkers, Janssen Pharmaceutica, Beerse, Belgium.
Guy BerbersCentre of Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, the Netherlands; and.
Rutger ScheppCentre of Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, the Netherlands; and.
Ashley UruchurtuNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Benedikt DitzDepartment of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Louis BontDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands.
James P AllinsonNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Maarten van den BergeDepartment of Pulmonology and Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Gavin C DonaldsonNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Peter J M OpenshawNational Heart and Lung Institute, Imperial College London, London, United Kingdom.ORCID 0000-0002-7220-2555
Jadwiga WedzichaNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
RESCEU Investigators
Imperial College London · GBUniversity Medical Center Groningen · NLJanssen (Belgium) · BENational Institute for Public Health and the Environment · NLWilhelmina Children's Hospital · NLAstraZeneca (United Kingdom) · GBNational Health Service · GB
Funding
The European Federation of Pharmaceutical Industries and Associations (EFPIA)
Abstract
PubMed holds no abstract for this paper.
Indexed as
Pulmonary Disease, Chronic ObstructiveRespiratory Syncytial Virus InfectionsAgedAged, 80 and overCohort StudiesCommunity-Acquired InfectionsDisease ProgressionFemaleHumansLondonMaleMiddle AgedNetherlandsProspective StudiesRespiratory Syncytial Virus, Humanchronic obstructive pulmonary diseaserespiratory syncytial virusrhinovirus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.